U of Colorado researchers find that even low-androgen triple-negative breast cancer responds to anti-androgen therapy

Clinical trials are underway of anti-androgen drugs against high-androgen triple-negative breast cancers, and new work from the University of Colorado Cancer Center shows the threshold for benefit from anti-androgen therapies may be much lower than previously thought. …read more

Source:: Cancer